A team of synthetic biologists at the Hong Kong University of Science and Technology (HKUST) has recently discovered a way that could increase synthetic mRNA's protein production efficiency by up to 10 times, which means the effectiveness of mRNA vaccines and drugs—such as those used against cancer, COVID-19 or other genetic diseases, will be greatly boosted with even less dosage of the mRNAs.